INT J CLIN EXP PATHO 润色咨询

International Journal of Clinical and Experimental Pathology

出版年份:2008 年文章数:7250 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:4.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2020-04-29 张丽瑾

    收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?

    10

    展开10条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2023-06-30 医路晋升 来自北京

    IF:1.4,又站起来了!

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2022-02-21 ms4000000175020740

    投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2023-01-25 ms4000001705670644 来自广东省

    好难啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-12-31 agile

    偏重的研究方向:肿瘤
    经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    老牌期刊和新出版期刊是否都要选一些?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-12-29 衣谷

    除文章内容和质量外,选刊时还需注意什么?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-08-15 hujinnan

    曾经被PubMed搜不出来过,现在能PubMed了吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-07-14 Joseph辉

    现在IF几分了

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=589954, encodeId=95f058995470, content=收到了文章接收的邮件,让缴费,但没收到invoice的邮件呢,有一样的吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=791b5313853, createdName=张丽瑾, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145644, encodeId=f2b9214564487, content=IF:1.4,又站起来了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200628/1100acdca53f4020b37a995c62cadf50/cfb5e0230e744dea9c07b62184d634de.jpg, createdBy=916e1609090, createdName=医路晋升, createdTime=Fri Jun 30 12:45:59 CST 2023, time=2023-06-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1195606, encodeId=95ef119560614, content=投稿一个星期了,目前处于Under Review,但是今天才发现没有收到投稿成功的邮件,请问这是为什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a06389737, createdName=ms4000000175020740, createdTime=Mon Feb 21 10:40:54 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111447, encodeId=117c211144ed3, content=好难啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad9b5384212, createdName=ms4000001705670644, createdTime=Wed Jan 25 21:51:32 CST 2023, time=2023-01-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1179235, encodeId=360d11e92355d, content=偏重的研究方向:肿瘤<br>经验分享:2021年《国际期刊预警名单(试行)》正式发布。 International Journal of Clinical and Experimental Pathology (IJCEP)已不在该预警名单中。 具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:07:45 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104650, encodeId=cb30110465055, content=老牌期刊和新出版期刊是否都要选一些?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104649, encodeId=8188110464997, content=除文章内容和质量外,选刊时还需注意什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008180, encodeId=c6591008180ff, content=曾经被PubMed搜不出来过,现在能PubMed了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/23/af0b58cacd803ef15f61f49669e127e1.jpg, createdBy=7c581737388, createdName=hujinnan, createdTime=Sun Aug 15 22:40:57 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999497, encodeId=2cfa99949e41, content=现在IF几分了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35c02077868, createdName=Joseph辉, createdTime=Wed Jul 14 19:06:13 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996803, encodeId=25a199680346, content=理学报纸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Tue Jul 06 13:47:39 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-07-06 ms3000001999514966

    理学报纸

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分